Silence Therapeutics to discuss Phase 2 divesiran trial results
Tweet Send to a Friend
Silence Therapeutics plc (Nasdaq: SLN) announced it will host a conference call and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


